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Summary 15 
Echinococcosis is a re-emerging zoonotic disease in Kyrgyzstan. In 2012, an echinococcosis 16 
control scheme was started that included dosing owned dogs in the Alay Valley, Kyrgyzstan with 17 
praziquantel. Control programmes require large investments of money and resources; as such it is 18 
important to evaluate how well these are meeting their targets. However, problems associated with 19 
echinococcosis control schemes include remoteness and semi-nomadic customs of affected 20 
communities, and lack of resources. These same problems apply to control scheme evaluations, 21 
and quick and easy assessment tools are highly desirable. Lot quality assurance sampling was used 22 
to assess the impact of approximately two years of echinococcosis control in the Alay valley. A 23 
pre-intervention coproELISA prevalence was established, and a 75% threshold for dosing 24 
compliance was set based on previous studies. Ten communities were visited in 2013 and 2014, 25 
with 18-21 dogs sampled per community, and questionnaires administered to dog owners. After 26 
21 months of control efforts, 8/10 communities showed evidence of reaching the 75% praziquantel 27 
dosing target, although only 3/10 showed evidence of a reduction in coproELISA prevalence. This 28 
is understandable, since years of sustained control are required to effectively control 29 
echinococcosis, and efforts in the Alay valley should be continued.  30 
Keywords: Echinoccocus, control programme, Lot Quality Assurance Sampling (LQAS), 31 
Kyrgyzstan 32 
  33 
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Key findings 34 
 Prior to control efforts, canine echinococcosis coproELISA prevalence was estimated at 35 
20.1% 36 
 Praziquantel dosing targets of 75% of owned dogs were met in 8/10 communities after ~2 37 
years of control  38 
 CoproELISA prevalence did not decrease in all communities, indicating the need for 39 
continued control 40 
 Lot quality assurance sampling is a useful tool to evaluate the impact of echinococcosis 41 
control efforts 42 
Introduction 43 
Echinococcosis is a neglected zoonotic disease (WHO 2010) caused by infection with the larval 44 
stage of cestode tapeworms in the genus Echinococcus (Eckert et al. 2004). Human cystic and 45 
alveolar echinococcosis are caused by E. granulosus sensu lato (Alvares Rojas et al. 2014) and E. 46 
multilocularis, respectively (Eckert and Deplazes 2004), and humans are usually infected by eggs 47 
released in the faeces of an infected carnivore host, often domestic dogs (WHO/OIE 2001). Both 48 
diseases are characterized by the formation of cysts, usually in the liver or lungs (WHO/OIE 2001), 49 
and may be fatal if untreated (Fujikura 1991, Moro et al. 2009). Echinococcosis affects mainly 50 
pastoral communities worldwide, although the burden of the disease varies greatly in different 51 
locations (WHO/OIE 2001). Echinococcosis is relatively common in Central Asia (Torgerson et 52 
al. 2006, Torgerson 2013, Usubalieva et al. 2013), and is a public health concern in Kyrgyzstan 53 
(Torgerson et al. 2006). There are concerns the disease is re-emerging, and human cases of cystic 54 
and alveolar echinococcosis have increased greatly since Kyrgyzstan’s independence from the 55 
Soviet Union in 1991 (Torgerson et al. 2006, Usubalieva et al. 2013, Raimkylov et al. 2015).  56 
 57 
In 2011, the Kyrgyz Ministry for Agriculture and the World Bank considered echinococcosis to 58 
be of sufficient concern to implement an intervention programme which included providing 59 
anthelmintics for dogs (World Bank 2010). Dosing of domestic dogs with praziquantel (PZQ) 60 
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began in the summer of 2012, with an aim to dose all owned dogs four times a year (WHO 2011). 61 
When implementing control programmes, it is important to evaluate how well these are meeting 62 
their targets (Schantz et al. 1995, Schantz 1997). However, as echinococcosis often affects rural 63 
and remote communities (Craig et al. 2007), the same challenges associated with implementing 64 
the control scheme will affect the evaluation of the control scheme itself. Relatively quick and 65 
easy evaluation tools are therefore beneficial to assess the impact of echinococcosis control 66 
schemes (see also van Kesteren et al. 2015). 67 
 68 
Coproantigen ELISAs have proved a useful diagnostic approach for canine echinococcosis (Allan 69 
et al. 2006, Craig et al. 2015). However, testing all dogs is difficult and therefore a sample of dogs 70 
is generally taken. In remote areas such as the Alay Valley, where communities and households 71 
may be scattered, it is difficult to attain large sample sizes for owned dogs not only because of 72 
logistical constraints, but also because many dogs are frequently free-roaming and people (and 73 
their dogs) may be semi-nomadic (van Kesteren et al. 2013). Lot quality assurance sampling 74 
(LQAS, Dodge et al. 1929), provides a statistically robust method of interpreting data despite 75 
requiring a relatively small sample size. The LQAS methodology has been adapted and simplified 76 
for application in field studies (Valadez et al. 2002), and has been applied to studies related to 77 
healthcare (see Robertson et al. 2006) and canine echinococcosis (van Kesteren et al., 2015). In 78 
order to evaluate the echinococcosis intervention programme, ten communities in the Alay Valley 79 
were visited in April 2013 and April 2014 and LQAS methodology was applied to assess 80 
praziquantel dosing compliance, and canine echinococcosis coproELISA prevalence. 81 
 82 
Methods 83 
Scheme for control of echinococcosis 84 
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The Kyrgyz Ministry of Agriculture, with financial support from the World Bank, proposed an 85 
echinococcosis control programme (World Bank 2010). The proposal aimed to improve the 86 
livestock sector in Kyrgyzstan, specifically aiming to increase productivity and reduce zoonotic 87 
diseases (World Bank 2010). Funding was allocated to several programmes, including the 88 
development of a national disease control action plan, establishment of an animal disease 89 
surveillance system, implementation of a national public information campaign, and 90 
implementation of a comprehensive nationwide vaccination and testing program for eight diseases 91 
of livestock and/or dogs (foot and mouth disease, anthrax, rabies, brucellosis, sheep pox, peste des 92 
petits ruminants, echinococcosis, and tuberculosis). One proposed project was the provision of 93 
anthelminthics to domestic dogs in an attempt to control echinococcosis (World Bank 2010). 94 
 95 
Praziquantel tablets were provided to local community veterinarians at regional centres (for Alay 96 
Valley communities this was either Daroot Korgon or Gulcha), with community veterinarians 97 
instructed to go around to the households in their communities once in each season (winter, spring, 98 
summer and autumn) and either dose household dogs themselves or leave tablets with dog owners 99 
and instruct them to dose their dogs if dogs were not present at the time (T. Sultanov, Taldu Suu 100 
veterinarian, pers. comm.). In addition, veterinarians provided dog passports to monitor 101 
praziquantel dosing. The programme in the Alay Valley was considered a pilot project, and 102 
between 2013 and 2014, an estimated 7,610 dogs were registered with dog passports and dosed 103 
four times per year (unpublished data provided by the Kyrgyz Ministry of Agriculture and Land 104 
Reclamation and the Kyrgyz State Inspectorate for Veterinary and Phytosanitary Safety). In 2015, 105 
the dosing campaign was expanded to other parts of Kyrgyzstan by the Kyrgyz Ministry of 106 
Agriculture, as well as being continued in the Alay Valley. Parallel to the dosing campaign, dog 107 
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culling campaigns are implemented in Alay Valley communities. These are not specifically aimed 108 
at reducing echinococcosis but at controlling dog numbers. Prior to culls, which occur somewhat 109 
randomly during the year, and vary per village, community members are advised to tether or lock 110 
up their dogs for a specified period; untethered dogs are considered unwanted and culled (A. 111 
Gaitanbekov, Sary Mogul community veterinarian, pers. comm.). 112 
 113 
Communities 114 
Ten communities in the Alay Valley were selected as part of this study. All were situated along 115 
the major road (A327) that runs through the valley from west (the border with Tajikistan) to east 116 
(the border with Xinjiang, China). The communities sampled were (from west to east): Kyzyl 117 
Eshme (39.57°, 72.27°), Kabyk (39.59°, 72.39°), Achyk Suu (39.47°, 72.50°), Jaylima (39.62°, 118 
72.59°),  Kashka Suu (39.64°, 72.67°), Kara Kavak (39.66°, 72.72°), Sary Mogul (39.68°, 72.89°), 119 
Taldu Suu (39.70°, 72.98°), Archa Bulak (39.69°, 73.08°) and Sary Tash (39.73°, 73.25°) – see 120 
Figure 1. All communities were small villages with up to ~400 households, and populations of 121 
between a few hundred to at most ~3,000 people (see also van Kesteren et al. 2013, Mastin et al. 122 
2015). 123 
Establishing a pre-intervention coproELISA prevalence 124 
Four communities (Taldu Suu, Sary Mogul, Kara Kavak and Kashka Suu) were visited in May 125 
2012, prior to the start of the World Bank intervention programme (Mastin et al. 2015). All 126 
available households (i.e. those where occupants were at home at the time we visited) in Taldu 127 
Suu, Sary Mogul and Kara Kavak were visited, and all dogs present were sampled. If the occupants 128 
of a house were not home, we selected a neighbouring house and inquired about the presence or 129 
absence of dogs in unavailable households to be able to accurately assess the dog population. Due 130 
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to time constraints it was not possible to census all dogs In Kashka Suu. Instead, random locations 131 
within the community were selected and the six nearest available households were registered, with 132 
enquiries made about dog ownership of unavailable households at neighbouring households to be 133 
able to accurately assess the dog population. This process was continued until approximately 50 134 
dogs had been registered in total. Based on estimation of total household numbers from satellite 135 
imagery, this process resulted in the registration of approximately 25% of all households in the 136 
villageThe number of dog faecal samples collected and analysed from each community was as 137 
follows: Kara Kavak=35, Kashka Suu=42, Sary Mogul=155, Taldu Suu=86 (Mastin et al. 2015).  138 
Lot Quality Assurance Sampling: faecal sample and questionnaire data collection 139 
A Lot Quality Assurance Sampling (LQAS) framework was adopted to evaluate the levels of 140 
canine echinococcosis in April 2013. A minimum of 19 dogs were sampled in Achyk Suu, Archa 141 
Bulak, Kabyk, Kyzyl Eshme, Jaylima and Sary Tash (a sample size of 19 is the smallest sample 142 
size that minimizes the risk of type A and B errors, see Valadez et al. 2002). To select dogs, a GPS 143 
coordinate for the centre of each community was determined using Google Earth images (based 144 
on imagery collected by the ‘SPOT5’ satellite in 2010). This location was taken as a starting point. 145 
Upon arriving at this point, the second hand on a watch was used to determine a random direction 146 
in which to walk, with a straight line then followed towards the edge of the community. Along this 147 
route, alternate households visited and if dogs were present they were sampled and questionnaires 148 
were administered to their owners. If a dead end or the end of the community was reached, the 149 
second hand of the watch was again used to determine at random a new walking direction and the 150 
same approach was used, until a minimum of 19 dogs had been sampled, with additional dogs 151 
sampled if time allowed (however one sample collected from Achyk Suu in 2013 was lost in 152 
transport).  153 
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 154 
In the remaining four communities (Taldu Suu, Sary Mogul, Kara Kavak and Kashka Suu), more 155 
extensive sampling was undertaken as part of another study in which all household sampled in 156 
2012 prior to the dosing campaign were sampled again in spring and autumn 2013 and 2014 to 157 
collect more detailed information on Echinococcus spp. in these communities with an aim to create 158 
a mathematical model of transmission (Mastin 2015, and Mastin et al., in prep). For these 159 
communities, maps of visited households were used to recreate the LQAS sampling approach – 160 
again, by selecting a theoretical start point in the centre of the community, choosing a random 161 
direction (using a watch) and selecting 19 sampled households in that direction from the ‘start 162 
point’, and including any dogs in these households. The number of samples analysed per 163 
community was as follows (shown as 2013;2014): Kyzyl Eshme=19;19, Kabyk=19;19, Achyk 164 
Suu=18;19, Jaylima=19;21, Kara Kavak=21;19, Kashka Suu=19;19, Sary Mogul=19;19, Taldu 165 
Suu=19;19, Archa Bulak=19;19 and Sary Tash=19;19.  166 
 167 
Dog owners were asked about the age and sex of their dogs, and when their dog was last dosed 168 
with PZQ. We expected that the start of the dosing campaign, as well as the start of an international 169 
research study on echinococcosis in the area, would increase awareness about echinococcosis in 170 
the local communities, as both veterinarians and researchers visiting local households often 171 
explained their work to dog owners. Also, the dosing campaign coincided with the appearance of 172 
public health notices on Kyrgyz television about echinococcosis (A. Gaitanbekov and T. Sultanov, 173 
local veterinarians, pers. comm). Therefore, in 2014, dog owners were also asked if they had heard 174 
of echinococcosis, and if they knew what caused the disease. Questionnaires were administered in 175 
Kyrgyz by a native speaker (Bermet Mytynova). Faecal samples were collected from around the 176 
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dog owner’s homes and subsamples were stored in 0.3% PBS Tween (Fisher Scientific, 177 
Loughborough, UK) with 10% formalin (sourced locally). Faecal samples were shipped at room 178 
temperature to the University of Salford, UK. 179 
 180 
The LQAS method was also used to determine whether the dosing programme was effectively 181 
reaching people in each community. Although praziquantel dosing schemes may aim to reach all 182 
owned dogs, it is unrealistic to assume a 100% compliance rate, with rates of <60% to >80% 183 
previously reported from Kenya and China (see Torgerson 2003). The World Bank aimed to dose 184 
dogs four times a year, and mathematical simulation models have shown that with dosing every 3-185 
4 months, a compliance rate of 75% can be effective in reducing transmission of echinococcosis 186 
(Torgerson 2003, Torgerson et al. 2003a). For this reason we set our criterion at 75% of dogs dosed 187 
in the four months prior to our visit. Because dog owners could often not remember the exact day 188 
of dosing, only the month was noted and all reported dosings in January, February, March and 189 
April were included as being within four months prior to our visit (samples were collected between 190 
6 and 20 April 2013 and 5 and 12 April 2014). Where the latest dosing was not known, it was 191 
assumed the dog had not been dosed in the previous four months.  192 
 193 
Choosing LQAS decision numbers 194 
Although simplified field manuals including decision numbers are available for LQAS sampling  195 
(Valadez et al. 2002), it is possible to calculate decision numbers more accurately if the population 196 
size and exact prevalence are known. This can be done using the hypergeometric distribution and 197 
applying the following formula (from Lemeshow et al. 1991): 198 
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P(𝑑 ≤ 𝑑∗) = ∑
(
NP0
d
) (
N(1 − P0)
n − d
)
(
N
n
)
𝑑∗
𝑑=0
 199 
Where N is the total dog population size in a community, P0 is the prevalence threshold, n is the 200 
number of dogs sampled, and d* is the decision number-1. The decision number must be an integer 201 
and should be the lowest possible integer at which P is greater than or equals 10%. If d* or fewer 202 
positive samples are obtained (i.e. if d is not reached), this is interpreted as some evidence that the 203 
true prevalence is lower than P0. For example, in Taldu Suu, a census of the dog population 204 
revealed there were 98 dogs in the community (N=98), the dosing target was set at 75% (P0=0.75), 205 
and the number of dogs sampled was 19. By adjusting d in the equation above, the probability of 206 
sampling at least d dosed dogs can be estimated, given that the true proportion of dosing was at 207 
least 75%. For n=11: 208 
∑
(
98 ∗ 0.75
11
) (98
(1 − 0.75)
19 − 11
)
(
98
19
)
= 0.06
𝑑∗
𝑑=0
 209 
 For n=12: 210 
∑
(
98 ∗ 0.75
12
) (98
(1 − 0.75)
19 − 12
)
(
98
19
)
𝑑∗
𝑑=0
= 0.16 211 
As such the decision number for which P exceeds or equals 10% was calculated as 12, meaning 212 
that any sampling round which found fewer than 12 dosed dogs would provide some evidence that 213 
the true proportion of dosed dogs was lower than 75%. R code for calculation of the decision 214 
number based upon the hypergeometric distribution is provided in the Supplementary Information. 215 
 216 
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In order to calculate N, data collected in May 2012 from Sary Mogul, Taldu Suu and Kara Kavak 217 
was used, and extrapolated from the randomly sampled houses in Taldu Suu (for details see Mastin 218 
et al. 2015). The size of the four villages was estimated using the ‘measure distance’ tool in Google 219 
Earth, to select the area that contained most of the houses. The number of dogs (from census data) 220 
was then divided by the area of the villages to give an estimate of the dog density (average of 1.56 221 
dogs/100m2, SE=0.30). The sizes of the other six communities were then estimated using Google 222 
Earth and the dog population estimated using the average dog density of 1.56 dogs/ha from the 223 
four main study villages (Table 1). It is worth noting that dog population numbers in the Alay 224 
Valley do fluctuate due to a bi-annual dog culling campaign. The data from May 2012 was 225 
collected just prior to dog culling and as such the dog population numbers shown in Table 1 are 226 
estimates extrapolated from populations that had not recently been culled. Because of this, and the 227 
irregular nature of the dog culling, we may have overestimated the dog populations present in some 228 
communities, which could affect decision numbers, particularly for communities with small dog 229 
populations. However sensitivity analysis found that even if dog populations were overestimated 230 
by a third, LQAS results for dosing compliance and coproELISA prevalence would not change, so 231 
uncertainty of exact population sizes is not considered further.  232 
 233 
P0 was set at the pre-intervention prevalence as calculated from the samples collected from Sary 234 
Mogul, Taldu Suu, Kashka Suu and Kara Kavak in 2012, and n was determined as the number of 235 
dogs sampled in each community in each year (18, 19 or 21). For praziquantel dosing, P0 was set 236 
at 75% (Torgerson 2003, Torgerson and Heath 2003a). 237 
 238 
CoproELISA 239 
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Details of the coproELISA are given in Mastin et al. (2015). Briefly, after decontaminating at -240 
80°C for ≥4 days (WHO/OIE 2001), faecal samples were extracted by homogenizing, shaking, 241 
and centrifuging at 2500r.p.m (1125g) for 5 minutes, and collecting the supernatant. Faecal 242 
samples were analysed for Echinococcus spp. coproantigen using a genus-specific sandwich 243 
ELISA (see Allan et al. 1992, Craig et al. 1995, van Kesteren et al. 2015). Supernatants of two 244 
known positive samples (one natural infection, one sample spiked with E. granulosus adult worm 245 
extract) were used as positive controls throughout. Three known coproELISA negatives from a 246 
very low endemic area (Falkland Islands) were also included as negative controls.  247 
 248 
The ‘pre-intervention’ faecal samples collected in May 2012 and the post intervention samples 249 
collected (LQAS) in April 2013 and April 2014 were analysed in two batches. Aliquots of all 250 
reagents were pooled to a sufficient volume to test all the faecal samples in each lot and mixed, to 251 
ensure minimum variation in coproELISA test conditions.  252 
 253 
Cut-offs for OD values were determined for the coproELISA using ROC curve panels (Gardner et 254 
al. 2006) of faecal samples of known infection status. These panels included arecoline purge 255 
samples from dogs in the Alay Valley (van Kesteren et al. 2013) and samples from necropsied 256 
dogs in communities in Hobukesar County, Xinjiang China (van Kesteren et al. 2015). The aim 257 
was to compare the pre-intervention data to the data collected in April 2013 and 2014, and as such 258 
cut-offs were chosen to give similar sensitivities (Se) and specificities (Sp) between the two 259 
batches of samples, rather than choosing cut-offs that necessarily maximized Se/Sp. For the pre-260 
intervention samples (May 2012) a cut-off was chosen that gave a diagnostic sensitivity of 90% 261 
and a specificity of 86%. For the post-intervention ‘LQAS’ samples (April 2013 and April 2014) 262 
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a cut-off was chosen that gave a diagnostic sensitivity of 89% and a specificity of 88% (Note that 263 
for this reason the pre-intervention coproELISA prevalence described here is different from that 264 
described in Mastin et al. 2015, which used a cut-off to maximize Se and Sp). 265 
 266 
Results 267 
Pre-intervention coproELISA prevalence 268 
The dog faecal samples collected in May 2012 (n=318) gave an overall average coproELISA 269 
prevalence of 20.1%, with a within-village range from 16.3% in Taldu Suu to 22.9% in Kara 270 
Kavak. Village differences were ignored for the purposes of the current study, and the P0 for 271 
coproELISA prevalence was therefore set at 20.1% 272 
Dog demographics and praziquantel dosing in April 2013 and April 2014 273 
A total of 191 dogs were sampled in April 2013. The majority of these (157 or 82.2%) were male, 274 
with 28 females (14.7%). For six dogs (3.1%) the sex was not recorded. Most dogs were younger 275 
than five years (131, or 69.3%, see Fig. 2, although the age of ten dogs was not recorded, and for 276 
6 dogs neither age nor sex was recorded. 277 
 278 
A total of 192 dogs were sampled in April 2014. The majority of these (156 or 81.3%) were male, 279 
with 35 females (18.2%). The sex of one dog (0.5%) was not recorded. Most dogs were younger 280 
than five years (156 or 81.3%, Fig. 3), and for 5 dogs the age/sex was not recorded. 281 
                                                        282 
In 2013, the majority of dog owners reported dosing their dog at some point in the seven months 283 
before sampling (141, or 73.8%, Fig. 4), with one person reportedly dosing their dog 11 months 284 
before sampling (0.5%). However 39 dog owners (20.42%) reported never dosing their dogs, and 285 
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a further 10 owners (5.2%) did not know when their dog had last been dosed, if ever (Fig. 4). In 286 
2014, 152 dog owners (79.2%, Fig. 4) reported dosing their dog in the seven months before 287 
sampling, with four dogs (2.1%) being dosed between 7 and 8 months prior to sampling. In 2014, 288 
23 dog owners (12.0%) reported never dosing their dogs and for a further 13 dogs (6.8%), the 289 
latest dosing was not known (Fig. 4). 290 
Local knowledge of echinococcosis 291 
In 2014, dog owners were asked whether or not they had heard of human echinococcosis, and what 292 
they thought caused human echinococcosis (open question). A total of 149 dog owners were asked 293 
these questions (some owners had multiple dogs, and some owners did not answer these questions). 294 
For the cause of echinococcosis, answers were classified as either ‘correct’, ‘incorrect’ or ‘partially 295 
correct’. ‘Correct’ answers included: dog faeces, foxes, wolves, and contact with dogs. If owners 296 
correctly identified dogs and dog faeces as possible sources of infection but also listed incorrect 297 
sources such as sheep or mice (which are potential sources of canine echinococcosis, but not 298 
human infection), these were classed as ‘partially correct’. If owners said they didn’t know what 299 
caused echinococcosis, or gave wrong responses, for example ‘livers’ (which would be correct for 300 
canine echinococcosis but not human echinococcosis) then the answer was classed as ‘incorrect’. 301 
Out of the 149 respondents, 126 (84.6%) had heard of echinococcosis, and 93 of these (78.3%) 302 
correctly identified causes of echinococcosis, with a further 13 respondents (10.3%) giving 303 
partially correct responses. 23 dog owners (15.4%) had not heard of echinococcosis and could not 304 
correctly identify its causes, but of the respondents who had heard of echinococcosis, 20 could 305 
also not correctly identify its causes. As such a total of 43 dog owners (28.9%) could not correctly 306 
identify causes of echinococcosis. 307 
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Using the LQAS method to evaluate PZQ dosing 308 
Although the majority of dogs were dosed in the four months prior to sampling in 2013 (109, or 309 
56.5%), there were marked differences between villages. None of 19 dogs were dosed in the 310 
previous four months in Sary Mogul in 2013, compared to 16 out of 19 dogs dosed in Jaylima in 311 
2013 (Table 2). Six out of ten communities (Archa Bulak, Kara Kavak, Kashka Suu, Kyzyl Eshme, 312 
Sary Mogul, Sary Tash) did not meet the LQAS decision number for praziquantel dosing, 313 
suggesting that the praziquantel dosing scheme failed to reach at least 75% of owned dogs in these 314 
communities in 2013 (see Table 2). 315 
In 2014, the overall proportion of dogs dosed no more than four months prior to sampling was 316 
higher than in 2013 (128, or 66.7%). Dosing compliance rates also seemed to have improved, with 317 
only two communities (Kashka Suu and Kyzyl Eshme) failing to meet the decision number (see 318 
Table 2). This suggests that the praziquantel dosing scheme was reaching more owned dogs in 319 
2014 than in 2013. 320 
Using LQAS to evaluate the impact of two years of intervention on coproELISA prevalence 321 
The LQAS methodology described above was also used to evaluate whether the coproELISA 322 
prevalence had decreased following the start of the intervention programme. P0 was set at 20.13% 323 
based on the pre-intervention sampling, and we aimed to identify villages that had achieved a 324 
reduction in their coproELISA prevalence.  325 
 326 
In 2013, five communities in the Alay valley (Archa Bulak, Kara Kavak, Kashka Suu, Sary Mogul 327 
and Sary Tash) did not meet the decision number set according to LQAS requirements (Table 3). 328 
In 2014, three communities (Archa Bulak, Jaylima, and Sary Tash) did not meet the LQAS 329 
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decision number (Table 3). These results provide some evidence that the canine coproELISA 330 
prevalence in these communities was lower than the pre-intervention value of 20.13%. 331 
 332 
Discussion 333 
 Echinococcosis is a neglected zoonotic disease that can be fatal in humans (WHO/OIE 2001) and 334 
can also have a large economic impact on rural communities due to the detrimental effects on 335 
livestock productivity (Benner et al. 2010). Echinococcosis is re-emerging in Kyrgyzstan 336 
(Torgerson et al. 2003b, Raimkylov et al. 2015) and was specifically mentioned as one focus of a 337 
livestock disease control programme in the country (World Bank 2010). However, echinococcosis 338 
is very difficult to control or eliminate (WHO/OIE 2001) especially in continental regions that are 339 
relatively remote and where people are nomadic or semi-nomadic (Schantz et al. 2003, Craig et al. 340 
2006). In these cases frequent praziquantel dosing of domestic dogs (standard recommended 341 
dosing every six weeks) may not be practically feasible (Gemmell et al. 1986, Lembo et al. 2013), 342 
and surveillance of the effectiveness of the scheme in the field is made even more challenging. 343 
 344 
The implementation of control programmes for echinococcosis is costly in terms of both financial 345 
and human resources, and as a result, control programmes have frequently not had the long term 346 
success hoped for (Craig and Larrieu 2006). As such, it is important to evaluate the real impact of 347 
control programmes, rather than focussing on easily-available metrics such as the amount of 348 
money spent, or the number of praziquantel tablets distributed. Effective evaluation of control 349 
programmes requires data to be collected from the communities in question, including reliable pre-350 
intervention data, and data collection should continue at suitable intervals during the control 351 
programme itself. The data collected will depend on the questions being asked, but of particular 352 
value are infection-centred measures such as the prevalence of canine infection (or the copro-353 
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prevalence, as a proxy), or the prevalence of human echinococcosis. However, the challenges of 354 
implementing control programmes will also apply to the evaluations of control programmes. As 355 
such, relatively quick and easy tools to evaluate echinococcosis control programmes are highly 356 
desirable. 357 
 358 
In order to evaluate the impact of the intervention programme in the Alay Valley, a pre-359 
intervention coproELISA prevalence was established (van Kesteren et al. 2013, Mastin et al. 360 
2015). To assess the impact of the control programme, ten communities were visited in April 2013 361 
and April 2014 (~9 and 21 months after the start of the dosing scheme). From these, we aimed to 362 
assess praziquantel dosing compliance and coproELISA prevalence, with the praziquantel dosing 363 
threshold set at 75% of dogs dosed in the previous 3-4 months (Torgerson 2003). In 2013, four of 364 
the ten communities reached the decision number associated with this dosing target, and in 2014 365 
this number had increased to eight out of ten. Although the LQAS methodology does not allow us 366 
to state that the target was reached for these communities, the number of communities for which 367 
there was evidence of the target not being met was lower in 2014 than 2013, which is suggestive 368 
that the dosing scheme was reaching at least 75% of owned dogs in most communities sampled. 369 
Furthermore, in 2014 a majority of dog owners (84.6%) had heard of human echinococcosis and 370 
could describe its causes (78.3%).  371 
 372 
In 2013, there was evidence that the copro-prevalence was lower than the pre-intervention estimate 373 
of 20.13% in five out of ten communities sampled. However, in 2014, this had decreased to three 374 
out of the ten communities sampled, despite the higher number of communities reaching the 375 
threshold for reported praziquantel dosing. Although LQAS methodology, by virtue of the small 376 
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sample sizes collected, does not lend itself well to individual-level interpretation, it was reported 377 
that over half of the 33 dogs found to be coproELISA positive in 2014 were reported to have been 378 
dosed within the previous four months. This may reflect information biases from owners regarding 379 
the timing of dosing, errors in dosing (for example, tablets not swallowed or incorrect dosages 380 
administered), or reinfection. Although praziquantel is highly effective in treating canine 381 
echinococcosis, it provides no protection against reinfection, and if dogs continue to have access 382 
to offal and/or small mammals, they may become re-infected with E. granulosus, E. canadensis 383 
or E. multilocularis: all three of which are known to be transmitted in dogs in the Alay valley (van 384 
Kesteren et al. 2013). Deworming dogs using praziquantel is considered to eventually reduce the 385 
infection pressure to dogs through decreasing the infection pressure to livestock and small 386 
mammals, although this takes time due to the longevity of cysts in livestock (e.g. Torgerson and 387 
Heath 2003a). Similarly, although the lifespan of voles and other small mammals is much shorter 388 
than that of sheep (Bobek 1969, Devevey et al. 2009), it will take 1-2 years for infected small 389 
mammals to die off (Moss et al. 2013). Furthermore, E. multilocularis transmission is expected to 390 
be less responsive to dog dosing campaigns due to its sylvatic lifecycle (Eckert and Deplazes 391 
2004). Therefore, even if dogs were correctly dosed, they may still be subject to high reinfection 392 
pressures, which may explain the poor correlation between reported praziquantel dosing and 393 
coproELISA prevalence.  394 
 395 
When using LQAS, it is important to be aware of the limitations of this methodology. LQAS 396 
methodology remains statistically robust in the presence of small sample sizes by operating on the 397 
group level rather than the individual level, and by classifying groups (in the current study, 398 
villages) in a dichotomous fashion. As a result, conclusions can only be made at the level of the 399 
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village, and individual-level associations within these villages cannot be assessed. This latter issue 400 
means that although possible reasons for a lack of association between praziquantel dosing and 401 
coproantigen positivity at the individual dog level can be postulated (see above), further studies 402 
would be required to evaluate this more fully. Another important consideration in interpreting the 403 
results presented here is that of limitations in the diagnostic test itself. It has been well reported 404 
that the coproantigen ELISA functions best in the presence of higher worm burdens (Allan and 405 
Craig 2006). Control schemes using anthelminthics may affect the degree of overdispersion in a 406 
community since treatment of high burden individuals (which contribute most to overdispersion) 407 
bring the mean worm burden closer to the threshold for detection using the coproantigen ELISA, 408 
resulting in greater instability in the prevalence estimates obtained when using a single cut-off for 409 
‘positivity’. It should also be noted that as pre-intervention coproELISA prevalences were 410 
estimated from the four communities (Sary Mogul, Taldu Suu, Kara Kavak and Kashka Suu) 411 
sampled prior to the dosing campaign, we are not able to draw detailed conclusions about 412 
individual communities, which would require more extensive data collection (e.g. Mastin 2015, 413 
Mastin et al. 2015). 414 
 415 
Surveillance of echinococcosis in domestic dogs allows for a practical evaluation of a control 416 
programme, with the benefit that dogs can be sampled and tested for Echinococcus spp. non-417 
invasively through coproELISA analysis of faecal samples collected from the ground (e.g. 418 
Pierangeli et al. 2010). In addition, the application of novel sampling methodology like LQAS can 419 
reduce some of the laboriousness associated with evaluating control programmes, and provide a 420 
relatively quick and easy tool to test if control programmes are meeting their targets. Here we 421 
found evidence that a minority of villages failed to reach reasonable levels of praziquantel dosing 422 
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by 2014, suggesting that the echinococcosis control programme was reaching the other 423 
communities. Although analysis of the canine infection data did not show evidence of a gradual 424 
decrease in coproELISA prevalence over time, longer timescales are required to evaluate these 425 
changes. Effective control of echinococcosis takes years if not decades, and a sustained effort will 426 
be required to reduce infection pressures and effectively control cystic echinococcosis in the Alay 427 
Valley, and the co-endemicity with alveolar echinococcosis in the Alay valley (Usubalieva et al. 428 
2013) also makes control more challenging. Fortunately control efforts in the Alay Valley by the 429 
Kyrgyz Ministry of Agriculture are ongoing, with an estimated ~6,000 and ~4,000 dogs treated in 430 
2015 and 2016 respectively, with an estimated total of 24,162 and 15,501 praziquantel tablets 431 
provided to dogs (unpublished data provided by the Kyrgyz Ministry of Agriculture and Land 432 
Reclamation and the Kyrgyz State Inspectorate for Veterinary and Phytosanitary Safety). 433 
Following the initial project in the Alay Valley, the control programme has been expanded to other 434 
parts of Kyrgyzstan. The LQAS methodology described here would provide a relatively low-cost 435 
method of evaluating canine infection status over the coming years, given that the control scheme 436 
is maintained. 437 
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Table1: Estimated dog populations in the 10 communities sampled.  542 
* indicates known dog number from census 543 
 ** indicates extrapolated dog number from sample 544 
 545 
Village name Estimated area 
(ha) 
Estimated dog 
number 
Estimated dog density 
(dogs per ha) 
Taldu Suu 37 98* 2.66 
Sary Mogul 121 157* 1.30 
Kara Kavak 31 35* 1.12 
Kashka Suu 105 120** 1.14 
Archa Bulak 16 25 1.57 
Sary Tash 56 90 1.61 
Kabyk 29 50 1.71 
Kyzyl Eshme 68 105 1.56 
Achyk Suu 61 95 1.56 
Jaylima 17 30 1.74 
 546 
  547 
25 
 
Table 2: Dogs dosed in the four months prior to sampling in each of the ten communities in April 548 
2013 and April 2014. Communities in bold type did not meet the LQAS requirements, meaning 549 
that for these communities there was evidence that fewer than 75% of households had recently 550 
dosed their dogs with praziquantel 551 
 552 
 553 
 554 
 555 
  556 
Community PZQ in prev. 4 ms No PZQ in prev. 4 ms Decision # Community PZQ in prev. 4 ms No PZQ in prev. 4 ms Decision #
Achyk Suu 13 5 11 Achyk Suu 16 3 12
Archa Bulak 11 8 13 Archa Bulak 17 2 13
Jaylima 16 3 13 Jaylima 19 2 14
Kabyk 15 4 12 Kabyk 14 5 12
Kara Kavak 10 11 14 Kara Kavak 16 3 12
Kashka Suu 10 9 12 Kashka Suu 5 14 12
Kyzyl Eshme 12 7 12 Kyzyl Eshme 4 15 12
Sary Mogul 0 19 12 Sary Mogul 13 6 12
Sary Tash 7 12 12 Sary Tash 17 2 12
Taldu Suu 15 4 12 Taldu Suu 16 3 12
2013 2014
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Table 3: CoproELISA positive and negative faecal samples in the ten communities sampled in 557 
April 2013 and April 2014. Communities in bold type met the LQAS requirements, meaning that 558 
for these communities there was no evidence of a decrease in coproantigen prevalence from the 559 
baseline of 20.1% 560 
 561 
 562 
 563 
  564 
Community CoproELISA +ve CoproELISA -ve Decision # Community CoproELISA +ve CoproELISA -ve Decision #
Achyk Suu 4 14 2 Achyk Suu 5 14 2
Archa Bulak 1 18 3 Archa Bulak 0 19 3
Jaylima 6 13 2 Jaylima 2 19 3
Kabyk 4 15 2 Kabyk 4 15 2
Kara Kavak 1 20 3 Kara Kavak 2 17 2
Kashka Suu 1 18 2 Kashka Suu 5 14 2
Kyzyl Eshme 3 16 2 Kyzyl Eshme 7 12 2
Sary Mogul 0 19 2 Sary Mogul 4 15 2
Sary Tash 1 18 2 Sary Tash 0 19 2
Taldu Suu 2 17 2 Taldu Suu 4 15 2
2013 2014
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 565 
Figure 1: Locations of the study sites within Kyrgyzstan (top) and a region of southern 566 
Kyrgyzstan (bottom). KE = Kyzyl Eshme; Ka = Kabyk; AS = Achyk Suul; Ja = Jaylima; KS = 567 
Kashka Suu; KK = Kara Kavak; SM = Sary Mogul; TS = Taldu Suu; AB = Archa Bulak; ST = 568 
Sary Tash 569 
  570 
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 571 
Figure 2: Dog demographics in the Alay Valley in April 2013, based on LQAS sampling of ten 572 
communities. (Note: age and/or sex of 16 dogs not recorded) 573 
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 574 
 Figure 3: Dog demographics in the Alay Valley in April 2014, based on LQAS sampling of ten 575 
communities. (Note: age and/or sex of 5 dogs not recorded) 576 
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 577 
Figure 4: Most recent praziquantel dosing for dogs in the Alay Valley in April 2013 and April 578 
2014 579 
 580 
